HuGE Literature Finder
Records
1
-
6
Histology-based molecular profiling improves mutation detection for advanced thyroid cancer. Genes, chromosomes & cancer 2021 3 60 (8): 531-545. Eszlinger Markus, Khalil Moosa, Gillmor Aaron Hill, Huang Helen, Stewardson Paul, McIntyre John B, Morrissy Sorana, Paschke Ra |
IGF2 is a potential factor in RAI-refractory differentiated thyroid cancer. Oncology letters 2021 6 22 (2): 590. Crezee Thomas, Tesselaar Marika H, Jaeger Martin, Rabold Katrin, Corver Willem E, Morreau Hans, Van Engen-Van Grunsven Adriana C H, Smit Jan W A, Netea-Maier Romana T, Plantinga Theo |
Akt1 genetic variants confer increased susceptibility to thyroid cancer. Endocrine connections 2020 Oct . Crezee Thomas, Petrulea Mirela, Piciu Doina, Jaeger Martin, Smit Jan W A, Plantinga Theo S, Georgescu Carmen E, Netea-Maier Roma |
Effects of the MTOR and AKT1 genes polymorphisms on papillary thyroid cancer development. IUBMB life 2020 Oct . Maruei-Milan Rostam, Saravani Mohsen, Heidari Zahra, Asadi-Tarani Mina, Salimi Saeed |
MassARRAY-based simultaneous detection of hotspot somatic mutations and recurrent fusion genes in papillary thyroid carcinoma: the PTC-MA assay. Endocrine 2018 07 61 (1): 36-41. Pesenti Chiara, Muzza Marina, Colombo Carla, Proverbio Maria Carla, Farè Claudia, Ferrero Stefano, Miozzo Monica, Fugazzola Laura, Tabano Silv |
Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1. Cancer research 2009 Jun 69 (11): 4885-93. Ricarte-Filho Julio C, Ryder Mabel, Chitale Dhananjay A, Rivera Michael, Heguy Adriana, Ladanyi Marc, Janakiraman Manickam, Solit David, Knauf Jeffrey A, Tuttle R Michael, Ghossein Ronald A, Fagin James |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: